Get started
Author

Marcos Meuser Batista

Observed names: Batista, Marcos M., Batista, Marcos Meuser, M. M. BATISTA, M. M. Batista, M.M Batista, M.M. Batista, MARCOS M. BATISTA, MARCOS MEUSER BATISTA, Marcos M. Batista
ORCID: 0000-0003-4783-7011
Observed ORCID: 0000-0003-4783-7011
OpenAlex ID: A5004209441
Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment
2010 · Denise da Gama Jaén Batista, Marcos Meuser Batista, et al. · Antimicrobial Agents and Chemotherapy · 83
In Vitro and In Vivo Studies of the Antiparasitic Activity of Sterol 14α-Demethylase (CYP51) Inhibitor VNI against Drug-Resistant Strains of Trypanosoma cruzi
2013 · Maria de Nazaré Correia Soeiro, Elen Mello de Souza, et al. · Antimicrobial Agents and Chemotherapy · 78
PDF
Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models
2003 · E. M. de Souza, T. C. Araújo-Jorge, et al. · Cell and Tissue Research · 75
Phenyl substitution of furamidine markedly potentiates its anti-parasitic activity against Trypanosoma cruzi and Leishmania amazonensis
2004 · E.M de Souza, A Lansiaux, et al. · Biochemical Pharmacology · 69
In Vitro and In Vivo Studies of the Trypanocidal Activity of a Diarylthiophene Diamidine against Trypanosoma cruzi
2008 · Cristiane França da Silva, Marcos Meuser Batista, et al. · Antimicrobial Agents and Chemotherapy · 63
CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds
2012 · Tatiana Y. Hargrove, Kwangho Kim, et al. · International Journal for Parasitology Drugs and Drug Resistance · 55
PDF
Activity of “reversed” diamidines against Trypanosoma cruzi “in vitro”
2007 · C.F. Silva, Marcos Meuser Batista, et al. · Biochemical Pharmacology · 55
Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain
2017 · F. H. Guedes-da-Silva, D. G. J. Batista, et al. · Antimicrobial Agents and Chemotherapy · 41
PDF
Activities of Psilostachyin A and Cynaropicrin against Trypanosoma cruzi In Vitro and In Vivo
2013 · Cristiane França da Silva, Denise da Gama Jaen Batista, et al. · Antimicrobial Agents and Chemotherapy · 40
PDF
Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies
2009 · Maria de Nazaré C Soeiro, Andréia P Dantas, et al. · Memórias do Instituto Oswaldo Cruz · 39
PDF
In Vitro and In Vivo Biological Effects of Novel Arylimidamide Derivatives against Trypanosoma cruzi
2014 · Bruno Lisboa Timm, Patrícia Bernadino da Silva, et al. · Antimicrobial Agents and Chemotherapy · 37
PDF
Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy
2017 · M.R. Simões-Silva, J.S. De Araújo, et al. · Biochemical Pharmacology · 35
Evidence for a perforin‐mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection
2002 · ANDREA HENRIQUES‐PONS, GABRIEL M. OLIVEIRA, et al. · International Journal of Experimental Pathology · 35
PDF
Repurposing strategies for Chagas disease therapy: the effect of imatinib and derivatives against Trypanosoma cruzi
2019 · M. R. Simões-Silva, J. S. De Araújo, et al. · Parasitology · 33
Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In Vivo
2011 · Denise da Gama Jaén Batista, Marcos Meuser Batista, et al. · PLoS ONE · 31
PDF
In Vitro and In Vivo Studies of the Trypanocidal Effect of Novel Quinolines
2017 · A. S. G. Nefertiti, M. M. Batista, et al. · Antimicrobial Agents and Chemotherapy · 28
PDF
Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection
2009 · Leticia Coutinho, Marcelo Alves Ferreira, et al. · Memórias do Instituto Oswaldo Cruz · 28
PDF
Antichagasic, Leishmanicidal, and Trichomonacidal Activity of 2‐Benzyl‐5‐nitroindazole‐Derived Amines
2018 · Cristina Fonseca‐Berzal, Alexandra Ibáñez‐Escribano, et al. · ChemMedChem · 27
Trypanosoma cruzi: Activity of heterocyclic cationic molecules in vitro
2009 · Michele Gabriele de Oliveira Pacheco, Cristiane França da Silva, et al. · Experimental Parasitology · 27
Phenotypic Screening In Vitro of Novel Aromatic Amidines against Trypanosoma cruzi
2016 · M. R. Simões-Silva, A. S. G. Nefertiti, et al. · Antimicrobial Agents and Chemotherapy · 26
PDF
Efficacy of Novel Pyrazolone Phosphodiesterase Inhibitors in Experimental Mouse Models of Trypanosoma cruzi
2020 · Julianna Siciliano de Araújo, Cristiane França da Silva, et al. · Antimicrobial Agents and Chemotherapy · 25
Repurposing Strategy of Atorvastatin against Trypanosoma cruzi: In Vitro Monotherapy and Combined Therapy with Benznidazole Exhibit Synergistic Trypanocidal Activity
2018 · C. F. Araujo-Lima, R. B. Peres, et al. · Antimicrobial Agents and Chemotherapy · 24
PDF
In Vitro , In Silico , and In Vivo Analyses of Novel Aromatic Amidines against Trypanosoma cruzi
2017 · Camila C. Santos, Jéssica R. Lionel, et al. · Antimicrobial Agents and Chemotherapy · 23
PDF
In vitro analyses of the effect of aromatic diamidines upon Trypanosoma cruzi
2009 · Anissa Daliry, Patrícia B. Da Silva, et al. · Journal of Antimicrobial Chemotherapy · 23
New pyrazolopyrimidine derivatives as Leishmania amazonensis arginase inhibitors
2019 · Livia M. Feitosa, Edson R. da Silva, et al. · Bioorganic & Medicinal Chemistry · 22
Works count: 65
Citation count: 1,248
H-index: 23
I10-index: 34
Year
Topic
Type